Document is current
Any future updates will be listed below
-
Authors
Wiull, Kamilla
Holmgren, Erik
Svensson, Samuel
Eijsink, Vincent G. H.
Grönlund, Hans
Mathiesen, Geir
-
Funding
Funding for this research was provided by:
Norges Miljø- og Biovitenskapelige Universitet
- License Information
-
More Information
Article History
Received: 2 September 2024
Accepted: 18 February 2025
First Online: 5 March 2025
Declarations
:
: SS is a shareholder and an employee at Neogap Therapeutics AB. HG is CSO, co-founder and shareholder in Neogap Therapeutics AB. KW, EH, VGHE and GM have no conflict of interest to declare.
